These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 12810504
1. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC. Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504 [Abstract] [Full Text] [Related]
2. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus. Doukaki S, Platamone A, Alaimo R, Bongiorno MR. J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072 [Abstract] [Full Text] [Related]
3. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent. Esmaili N, Chams-Davatchi C, Valikhani M, Farshidfar F, Parvaneh N, Tamizifar B. Eur J Dermatol; 2008 Feb; 18(2):159-64. PubMed ID: 18424375 [Abstract] [Full Text] [Related]
4. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA. Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835 [Abstract] [Full Text] [Related]
5. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids. Almugairen N, Hospital V, Bedane C, Duvert-Lehembre S, Picard D, Tronquoy AF, Houivet E, D'incan M, Joly P. J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258 [Abstract] [Full Text] [Related]
6. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study. Ioannides D, Apalla Z, Lazaridou E, Rigopoulos D. J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):855-60. PubMed ID: 21752101 [Abstract] [Full Text] [Related]
7. Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris. Baskan EB, Yilmaz M, Tunali S, Saricaoglu H. J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1432-4. PubMed ID: 19470052 [Abstract] [Full Text] [Related]
14. An evaluation of the usefulness of mycophenolate mofetil in pemphigus. Powell AM, Albert S, Al Fares S, Harman KE, Setterfield J, Bhogal B, Black MM. Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207 [Abstract] [Full Text] [Related]
15. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. Olszewska M, Kolacinska-Strasz Z, Sulej J, Labecka H, Cwikla J, Natorska U, Blaszczyk M. Am J Clin Dermatol; 2007 Jul; 8(2):85-92. PubMed ID: 17428113 [Abstract] [Full Text] [Related]
16. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent. Katz KH, Marks JG, Helm KF. J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729 [Abstract] [Full Text] [Related]